Ilenia Calcaterra: Impact of Pain on Severe Haemophilia A Patients Receiving Emicizumab Prophylaxis
Ilenia Calcaterra, Researcher at University of Naples Federico II, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Haemophilia, adding:
”I am pleased to share our new publication in Haemophilia:
‘Use of the Multidimensional Haemophilia Pain Questionnaire (MHPQ) in Patients With Severe Haemophilia A Treated With Emicizumab: A Pilot Cross-Sectional, Single-Centre Study’
In this pilot study, we used the Multidimensional Haemophilia Pain Questionnaire (MHPQ) to assess the prevalence, characteristics, and functional impact of pain in adults with severe haemophilia A receiving Emicizumab prophylaxis.
Despite effective bleed control, pain remained a clinically relevant burden: 77.8% of patients reported pain within the previous 12 months, most commonly involving the ankles and knees, with an impact on daily activities, walking ability, mood, and enjoyment of life.
These findings suggest that, in the non-factor prophylaxis era, haemophilia-related pain is not exclusively bleeding-driven, but reflects a more complex and multidimensional phenotype.
Integrating structured pain assessment tools into routine haemophilia care may help better identify patients’ needs and support more personalized, multidisciplinary management strategies.
My sincere thanks to all co-authors, patients, and patient associations who continue to support clinical research in haemophilia.”
Title: Use of the Multidimensional Haemophilia Pain Questionnaire (MHPQ) in Patients With Severe Haemophilia A Treated With Emicizumab: A Pilot Cross-Sectional, Single-Centre Study
Authors: Ilenia Lorenza Calcaterra, Sofia Donnarumma, Guido D’Errico, Carmine De Luca, Chiara Caputo, Paola Ciciola, Ernesto Cimino, Matteo Di Minno

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 22:59Debbe McCall: Should Frail Elderly Patients Stable on Warfarin Switch to DOACs?
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation